RGNT · Regentis Biomaterials Ltd.
Market Cap
$14.05M
Shares
7.02M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.00
Open$2.10
Day$2.00–2.10
Available close range$1.28–9.40
Avg vol 30d86K
Short int8K · 0.1% float · 1.0d
Short vol46%
DataDec 2025–Aug 2026
The closing range uses available history since Dec 4, 2025; less than a full year is stored.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
−24%
below
RSI (14)
45
neutral
MACD trend
Positive
52-week position
9%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+15%
trailing
6-month return
−40%
trailing
YTD return
−70%
this year
Relative strength
−54%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+100% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.12% of float · ▼ -77.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — 13F breadth
Squeeze score
20
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
648%
annualized · 1-yr
Max drawdown
−83%
past year
ATR
11.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
−24%
Bearish
RSI (14)
45
Neutral
MACD trend
Positive
Bullish
52-week position
9%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
+100% holders QoQ · +4 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.12% of float · ▼ -77.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — 13F breadth
Price context
position in its available closing range
Range low $1
Now $2 · 9%
Range high $9
vs 50-day avg -24%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Instruments & Supplies — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RGNT
this stock
Regentis Biomaterials Ltd.
|
$14.05M | -70.3% | — | — | 0.1% |
|
ISRG
Intuitive Surgical Inc
|
$131.63B | -34.2% | +20.5% | 42.8 | 2.0% |
|
BDX
Becton Dickinson & Co
|
$51.24B | — | +8.2% | — | 3.4% |
|
MDLN
Medline Inc.
|
$46.38B | -16.0% | +11.5% | — | 2.8% |
|
ALC
Alcon Inc
|
$34.83B | -8.6% | +10.5% | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
6
- % held
- 12.0%
- Net QoQ
- +293.9K sh
- Top holder
- Rosalind Advisors, Inc.
Held
Float
Short & Settlement
Financials
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RGNT | -4.8% | +14.9% | -40.2% | +14.9% | -70.3% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -5.2% | +12.0% | -53.7% | +12.0% | -83.2% |